ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000875.1|Caprazamycin_1 # 3 # 209 # -1 # ID=1_1;partial=10;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.585	BGC0000875.1|Caprazamycin_1 	3	209	-	Loose	700	21.9422	vanS gene in vanC cluster	53.85	3002933	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	TTGCCGTGGCCTGAGCTGCCTAACGGCACCGCCTCGAAGCCGCGCAACATACCGAATCCCCCGTTCTGGCGAATACTCCGGTTCGTCGGTGACGCCTGGAAGATCACCGATTCTCAGAAAGACCGCCGGTCATATGACTCGCTTCATTACTACGACATCAGACGTGACGACATCCACTTGCTTTGCGTCAATCCTGCGGGCGCCGCC	MPWPELPNGTASKPRNIPNPPFWRILRFVGDAWKITDSQKDRRSYDSLHYYDIRRDDIHLLCVNPAGAA	MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWLFCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPSKRITLSSHLIDVQEEMNQLREKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEIALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLNLQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEMIGRLFEPFYRMDSSRATATSGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPANN	19.11	gnl|BL_ORD_ID|904|hsp_num:0	966			138	177	vancomycin
BGC0000875.1|Caprazamycin_2 # 247 # 1149 # 1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.690	BGC0000875.1|Caprazamycin_2 	247	1149	+	Loose	230	46.595	ramA	32.08	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	TTGGCGCGGCGTACCGGGGACACGCGGCATCAGAGCACCGCGTTCCGCAATGCCCGTCCGGTTCTGGAGACGGCTGAACTGGGCAGCGTCACGGCGCACCGGATCAGGTTCGGCGCCGGGTGCACCGGTCCGCACGTGCTGGCGCCTGCTCCCGGGCAGCACGCCCTCGTCCTCAGTGCGCGCGGTGAGACGAGGATCGCGCGAGGCGGGCGCGAGGTCGTCGTCCAGGGCGAGGCGGTGGCACTGTGCGACACCCGGCACCCGCTGCACATCAGCCCGAGGCCGGCGACCCGGACGGCCGAAGCGGTCGTGATGCTCTTCCCGGGTTCGGCCGTACCGATGACGCAGACGGAAACTGTCCCGGCGCAACCCGAGATCTCCGACGTCACGGGATCGGGATCACTGCTCCGCGCGTTCCTCGTCGAGGCCGCCACCCTGGCGTCACTGAGCGCACACGAGGCGGCCCGGCTCGGCGACGCCGCACTGCACCTGGCCGCAGCGGTGCTGGAGGCGTACTTCTTCGACGCCGGAGAGACGAGGGCACAGACGCAGCAGCAGGAGCTCATGACGCGGATCCGAGGATTCATCGACCGCAACCTCGGCGATCCCGACCTCACGCCGAGCCTGGTCGCCTCGGCCCACCACATCTCCATCCGCTGTCTGCAACGGCTGTTCAAGGCCGAGGGCAGTACTCCGTCGGAATGGATCCGTCAGCGCCGGCTGGACAACAGCCGGCGTGAACTCTGCGACGTGAGTCTCCGCTCGGCATCCATCCGGGAAATCGGCCTGCGTAACGGTTTCGCCCAGGCGTCCGACTTCAGCCGGGTGTTTCGTGGCCGCTACGGTGTCCCGCCGGGTAAATTCCGCGACGACTGGTTCCGGTGGGGCGCGATCAGTCAATAG	MARRTGDTRHQSTAFRNARPVLETAELGSVTAHRIRFGAGCTGPHVLAPAPGQHALVLSARGETRIARGGREVVVQGEAVALCDTRHPLHISPRPATRTAEAVVMLFPGSAVPMTQTETVPAQPEISDVTGSGSLLRAFLVEAATLASLSAHEAARLGDAALHLAAAVLEAYFFDAGETRAQTQQQELMTRIRGFIDRNLGDPDLTPSLVASAHHISIRCLQRLFKAEGSTPSEWIRQRRLDNSRRELCDVSLRSASIREIGLRNGFAQASDFSRVFRGRYGVPPGKFRDDWFRWGAISQ	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	241.94	gnl|BL_ORD_ID|1537|hsp_num:0	1665			48	354	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000875.1|Caprazamycin_3 # 1437 # 1847 # 1 # ID=1_3;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.611	BGC0000875.1|Caprazamycin_3 	1437	1847	+	Loose	525	23.8682	EVM-1	40.0	3006886	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EVM beta-lactamase	TTGGCGCTCCAGCATCGGCCGGAGGCGACGGACCCGTGGTACGAAGGCTGCCAGAGGCAGTCGCTGATCTCCTCGGACTCCGACTTCACCGAAGTGCACGGCGAACTCCGGGACACATATCTGGGCGAGGTCTTCGACCGGCTTCCGTTCAAGCCCATTCGCACGAGGATCATGGCGCTCGATCCGAAGTACTGCTATTCGGTGCACCGTGACCTGACACCGCGATACCACCTCGCCGTCACCACGAGTGAACACGCCAGGTTCGTGTTCATCGAGCACGACAAGGTGCTGCACATTCCCGCAGACGGAGACCTGTACTACGTCGACACGCGGCAGCTGCACAGCGCGTTCAATGGTGGTGACGACATGCGGATCCACATTGTTTTCGGGACGGACGGCGAGTCGAAGTAG	MALQHRPEATDPWYEGCQRQSLISSDSDFTEVHGELRDTYLGEVFDRLPFKPIRTRIMALDPKYCYSVHRDLTPRYHLAVTTSEHARFVFIEHDKVLHIPADGDLYYVDTRQLHSAFNGGDDMRIHIVFGTDGESK	MSVKFLVPIAFALSGCAVLPPPIQTPEPLPPAEEVQPEQWAATCEPWDDWDKPAPPYRIFGSTYYVGTCGISAILIAGDDGHILIDSGTEEGAEVVMDNIQKLGFRLNEIASILHSHEHFDHVGGLAKLRAATGAHIVSSAEAAKVLSTGEDHPEDPQFGVHEPMEPVQVDVIVEDGDTVRTETATVTAHATPGHSPGALSWTWVSCSLPGEPPACSRIAYVDSLSAVSSDDYRFTDHPEVVAAFRTSIDKVRSLPCDILLTPHPSSSQLIERLRTGTLGAPGKCATYAAQLGDKLDERLAKENP	44.59	gnl|BL_ORD_ID|3531|hsp_num:0	4600			180	270	
BGC0000875.1|Caprazamycin_4 # 1876 # 2499 # 1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0000875.1|Caprazamycin_4 	1876	2499	+	Loose	730	28.8758	farA	35.85	3003961	protein homolog model	n/a	n/a	antibacterial free fatty acids	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGGTGGCGCATTGGGACCGCCGCGCCGAGAGCTATGACGCAACACCGGGGAACTCGCTGTCGCCGGAACAGGCGGCGGCGTGGGGCGCGCTGCTGGCCGAGGTCTACCCGGTCCACACCGGCAGGCTGCTCGACATCGGCTGCGGGACGGGCACCTACTCGTTGCTGATCGCGGAACTGGGATTCGACGTGCATGGGGTGGACACCTCGGAGCGGATGGTCGAGCGGGCGCGGGCGAAGGCACTCGAACGCGGCGCCGGCCCCGGTGTCAGTTTCTCCACCCTCCCCGCGCAGGACATCAGCGGCCAGTACGACGCCGTGTTCTCCCGGAACGTGCTGTGGACCGTCGCGGACCCCGGCCGACTGGCCGAGACAGTGCGGGAGCACACCACGGAGTCCGCGGTGTGGATCGCCGTCGAGACGATGTGGGACGGCCACCCCAGGGGCGACTTCCGGGAAGCGGGAAAGGACCTGCCAGGATTCGGCGGCTGGCACCCCAATGTGCTCCGAGACGTGTTCACGCGGCACGGATTCGCACGGACGACGTGGTCCAGCATCTCCAACCGGCCGGATCTGGCGACCCAGGACAGGGACGTCCACGTGCTGTTCCGGGTGAGCCGGTGA	MVAHWDRRAESYDATPGNSLSPEQAAAWGALLAEVYPVHTGRLLDIGCGTGTYSLLIAELGFDVHGVDTSERMVERARAKALERGAGPGVSFSTLPAQDISGQYDAVFSRNVLWTVADPGRLAETVREHTTESAVWIAVETMWDGHPRGDFREAGKDLPGFGGWHPNVLRDVFTRHGFARTTWSSISNRPDLATQDRDVHVLFRVSR	MDTHTDETKLQNTQAKRKRRLTALTLLFALAAAAAGSAFFLWWQHEEETEDAYVAGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRRQNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAALAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQVAAGAPLMAVVPLSDVWVDANFKETQLRHMKIGQPAELVSDLYGKQIVYRGRVAGFSAGTGSAFSLIPAQNATGNWIKVVQRVPVRIVLNREDVDRHPLRIGLSMTVKVDTSAAGAPVSKTPGAALPEMESTDWSEVDRTVDEILGQSAP	53.91	gnl|BL_ORD_ID|2189|hsp_num:0	2428			807	948	palmitic acid; oleic acid; linoleic acid
BGC0000875.1|Caprazamycin_5 # 2598 # 3065 # 1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.690	BGC0000875.1|Caprazamycin_5 	2598	3065	+	Loose	375	33.8834	tmrB	31.33	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	TTGGGATTCGCCCTGATGGAGTTCCGTTCCGACCTGCCGGACAACTTCCAGGAGGACCCCGTCTGGGAGGGACTGTTCACCGCGCTGTGCGTGTTCACCGCCCGGCGCCGGAACGGCACCAGCGTACTGGCACCGATGAACATCCACTCGAGCGAGCGCCTGGCCAGAGTACGGGCCGCCCTCACCGGCCAGGGAGAGGCGGTCCACGTAGTGGGCCTGCGGTCGTCCCGGGAGCACTGCGAGCGCCTGGCGGACACCTTCTCGTTCTTCGAGACGGGATCGCCGGACTACCACCGCGTGCGCGACTGGCAGTTGGCACGGATGGGCGAGTACCTGGACTTCATCGCCGATCCGCACGCACCGGTCGACCACTGGATCGACCTGGGACCGGACGCGTCGGCCGAGTGGGTGGCCGCGTCGATCGCCGGGGCGGTGAGCCCTCTGGTCGCGGCGGAGGCAGCCACATGA	MGFALMEFRSDLPDNFQEDPVWEGLFTALCVFTARRRNGTSVLAPMNIHSSERLARVRAALTGQGEAVHVVGLRSSREHCERLADTFSFFETGSPDYHRVRDWQLARMGEYLDFIADPHAPVDHWIDLGPDASAEWVAASIAGAVSPLVAAEAAT	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	78.68	gnl|BL_ORD_ID|1654|hsp_num:0	1794			102	339	tunicamycin
BGC0000875.1|Caprazamycin_6 # 3136 # 4461 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000875.1|Caprazamycin_6 	3136	4461	+	Loose	500	26.1794	OXA-60	44.83	3001808	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGGCCTGTCGGGAGGACGTCGTGGCGGAGATCAGCGACGCCGAGTGCGTGGTGGCGTACCGGCGTCTGCGCGACGGGGTCCGCACCACGCGGCAGATCGGCTACGGCCGCAACATGTACCCGGCCGCTCCCGAACTCGTCGCACGGATCCGCGGGTTGGTCACCACACTGTTCGAGCAGCAGCGCATGACGGACTACTCCACCGAGTTCGACGGCGCCGACCGGCAACTGATCAGCGCCTTGGTCCGGGAGTGGCTGGGGCGCCCCGACATCGAGCCGGACGACGTGTTCGTCATGGCCGGGTCGACCGAGGCGATCAGCGTGGTCACCGGGTACCTCGCCGGACGCGGATACGGGTACGTGCTGCCGCTGCCGTGCTACTACGCCTTCGAGCAGTCCGCCAAGCGCTGGGGGATGCCGGTCCACGCCCACTACAACGGCGACGGCGTGCTGCACGGCACCCGGCCGGACTCGCCGTGGGCCCTGGTCGACATCGTGCCGAACGGTGTGACCGGCCGCCGCTTCCGGCTGCCGGACGGCACCGGCGACGACTTCCGCGTCATCGACTCGGTCTTCCAGGTCTCGGCTGCGCCCGGCCCCGGGCCCGCGGTCGACGACAGGCATCTGCTCGATGCGGTCCGGGGCGTCGACCTCGGCAGGAGTTGCGTGATGCTGACCGCCAGCAAGGACCTGTCCGTCCCCGGACTGCGTGCGGGCCTGCTGATCACCAGGGAGCCCGGCCTCAGGCGGTACCTGGAGGCGGACCGCTTCGAGCGGTGCTATGCGCTGAATCCGCTGTCCACCAGCGTCATCGCCCTGTACGTTGCCCTCATGTGCGCGCGGGCGGCGCGGGCGAAGGGCGCCGTGGCACCGGGACACCCACTGGTACCTCCCGAGGTCGCGCTGGGCCGGCCGACCGCCGACGATCCGCTCGCGCGGCTGCTGTGGCAGTCACCGATCGTCGACGCCCTCGACCGGTATCTGAACGGCATGGCCCGGCACTACCAGGCCGTTCTGGACATCTACCGGAACCGCCTCCCGCCGCTCGGAATCGATGTCGCGTTCCGGTGCCCGGAGACCGGCTACTCCCTGTTCCTGCCGCTGCCGGTGCGCGTCGAGGGACCGGAGGGCGCCGTGGAGTGGTGCAACCGGGTCGGCCGGGAGGCGGGACTCAAGCTCAATCCGGCAGCGATCTTCGGGGGAAGCGACGCACCGTGGACGGCCCTTTACGACTGCACGCGCCCTTGGGCGCGGTTCAACTGTTCGGTCGCGGAGCCGGATGCCGTCGGCACCGTGGACATTCTCGCGACAGCATTGAGGTGA	MTACREDVVAEISDAECVVAYRRLRDGVRTTRQIGYGRNMYPAAPELVARIRGLVTTLFEQQRMTDYSTEFDGADRQLISALVREWLGRPDIEPDDVFVMAGSTEAISVVTGYLAGRGYGYVLPLPCYYAFEQSAKRWGMPVHAHYNGDGVLHGTRPDSPWALVDIVPNGVTGRRFRLPDGTGDDFRVIDSVFQVSAAPGPGPAVDDRHLLDAVRGVDLGRSCVMLTASKDLSVPGLRAGLLITREPGLRRYLEADRFERCYALNPLSTSVIALYVALMCARAARAKGAVAPGHPLVPPEVALGRPTADDPLARLLWQSPIVDALDRYLNGMARHYQAVLDIYRNRLPPLGIDVAFRCPETGYSLFLPLPVRVEGPEGAVEWCNRVGREAGLKLNPAAIFGGSDAPWTALYDCTRPWARFNCSVAEPDAVGTVDILATALR	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	162.73	gnl|BL_ORD_ID|38|hsp_num:0	47			408	495	cloxacillin; oxacillin; cefalotin
BGC0000875.1|Caprazamycin_7 # 4466 # 5740 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.690	BGC0000875.1|Caprazamycin_7 	4466	5740	+	Loose	500	25.409	OXA-258	25.25	3001503	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACGGTGAGGGCTGCTGGAAAGACATCCGCGGACGCCGACCCGCTCGCGCTGGCCAGGGCGATAGCCGACGCCGACCGGCGGGCGGCGTCCGCCCTCAACCTTGTGCCCAGCGAGAACCGGGTCTCGCCACTGGCCTCCCTGCCGCTCGCCTCCGACTTCTACAACCGGTACTTCTTCAACACCGACGGCGACCCGCTGTTCTGGGAGTTCCGCGGCGGGGAGGACATCGCGCACATCGAGGCGCTCGGAGCCGCGGCGTTACGCCGGATGGCCATGGCGCGGTACTGCAACCTGCGCCCCATATCGGGGATGAGCGCGATGATCCTGACTGTCGCCGCCCTGTCGAAACCCGGATCGACCGTCGTGAGCGTGGACCAGGACTCCGGCGGCCACTACGCCACCCCGGCGTTGCTCGGCCGTCTGGGCCGACGGTCCCGGCTGCTCACCTGCAAGGACGGAGCAGTCGACGAGTCGGAACTCGCGGACGTGCTCGCACCCGGCGGCGTGGACCTCGTCTACGTGGACGTGCAGAACTGCGTCAGGGTGCCGGACTTCCGCCTGATGTCGGACGTGATCAGAAATGTCAGCCCGGGCACGCGGCTGTACGTCGACGCCAGCCACTACCTCGGCCTCGTTCTCGGCGGCCTTGTCGACAACCCCCTGGACTGCGGTGCGGACGCCTACGGCGGATCGACCCACAAGTCGTTCCCCGGGCCGCACAAGGGAGTGATCTTCACCAACGCCGAGGACGTCGACGAGAGTCTGCGGTCCGCCCAGTTCGACCTGGTCAGCAGCCACCACTTCGCCGAGACGCTGGCGCTGTCCCTGGCAGCGCTGGAGGTCGAGGACCGGATCGGGGACTACGCCCGGGCGACGAACGACAACGCGCGACGACTCGCAGGCGCGCTGGCCGAGGCGGGTTTCCGGGTGTGCGGCGACACCGGCACCGGATACACCGACACGCACCAGGTGTGGGTGGAACTGGCCGGCACCGACGAGGCCTACGCGCTGTCGAACCGGCTGGCCGAGGCGGGAATCCGGGTCAATCTGCAGTCGTCGATGCCGGGGATGTCCGGTGTGCACCTGCGTCTCGGCTCGAACGAGGTCACCTTCGAGGGCGCCGGTCCGCAGGCGATCGAGGAGCTCGCGGGCGCCCTGGTCCAGGCGAGAGAGCGAGCGCTGGGACCGCACACGGTGAGTGAGATCCGCGGGCGGTTCGGTGCCCCCTTCTACACCGATCCGGAGAAGCTGAAAGTGGAGGCAGGGCTGTGA	MTVRAAGKTSADADPLALARAIADADRRAASALNLVPSENRVSPLASLPLASDFYNRYFFNTDGDPLFWEFRGGEDIAHIEALGAAALRRMAMARYCNLRPISGMSAMILTVAALSKPGSTVVSVDQDSGGHYATPALLGRLGRRSRLLTCKDGAVDESELADVLAPGGVDLVYVDVQNCVRVPDFRLMSDVIRNVSPGTRLYVDASHYLGLVLGGLVDNPLDCGADAYGGSTHKSFPGPHKGVIFTNAEDVDESLRSAQFDLVSSHHFAETLALSLAALEVEDRIGDYARATNDNARRLAGALAEAGFRVCGDTGTGYTDTHQVWVELAGTDEAYALSNRLAEAGIRVNLQSSMPGMSGVHLRLGSNEVTFEGAGPQAIEELAGALVQARERALGPHTVSEIRGRFGAPFYTDPEKLKVEAGL	MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPVKAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFARLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK	154.74	gnl|BL_ORD_ID|1531|hsp_num:0	1659			402	648	cloxacillin; oxacillin; cefalotin
BGC0000875.1|Caprazamycin_8 # 5831 # 6646 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000875.1|Caprazamycin_8 	5831	6646	+	Loose	555	26.1794	OXA-457	28.57	3003613	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGTCGAGTTACACGGATCTCCCCGCCCGCGGCCCTGTGACCGACCTGCTGAAGCCGGACGAGACCCTCGACATGCTGGAGACCTATGGCCTCGCGGTGACGCAGAGCCCGTCGGCGACCGTGTCACCGGCCGATGCCCACAGCGAGATGGCCGCGATACGCGCCGACTTCGGCCTGGGGGAGCCCTATGTCCCGCTGCTCTACCGCGGCCGGGACACACCGATCGTCACCGAGGTGACACGGAAGGGGGACTCGGACCACCCGGTCTTCCACACCGGCGAGGCGCAGGGCTGGCACACCGACGGGCTCCTCGAGGACATCGGGACCATCAAGACGACACTGCTGTACTGCGTGTCCCCGGCGTACCGAGGTGGCAGGACGTTCCTGCTCAACGCCGGGCGGGTCTTCGAGGAGCTGAGGACGGAGGACCCCGAGGCGGCCGACGTGCTGATGCGGGACACGATCCTCGGCAGGCGGTCGACGATTCCCGGCGTGAACCGGGAGGCCGTCGGGCCCGTGTTCGCCGAACTCGGCGACGGCCACTACGCCACCCGGTACGGCGAGGGACGCGTGGAACGCTGGTACCCCGGGGACGCCGCGCAACGGCGCGCGCTCGATCGTGCGCTGCGCCACTTCCGGATGCGCCGTGACGACCCGGACGTCCGCATCGACCTGCTCCTCCAAGCCGGCCAGTGCCTGATCTTCCGCAACGACGTGCTGGCCCACGGCCGGGAGAACTTCACCGACGACCCGCAAAGTCCCCGCCTGCTCATGCGCAGCCTGCACACCAACGCCCCGAAGAACACGTCATGA	MKSSYTDLPARGPVTDLLKPDETLDMLETYGLAVTQSPSATVSPADAHSEMAAIRADFGLGEPYVPLLYRGRDTPIVTEVTRKGDSDHPVFHTGEAQGWHTDGLLEDIGTIKTTLLYCVSPAYRGGRTFLLNAGRVFEELRTEDPEAADVLMRDTILGRRSTIPGVNREAVGPVFAELGDGHYATRYGEGRVERWYPGDAAQRRALDRALRHFRMRRDDPDVRIDLLLQAGQCLIFRNDVLAHGRENFTDDPQSPRLLMRSLHTNAPKNTS	MTVRLFSTALGAALSLSALAGAPAQAAILCTVVADAADGRIVYQQGTQQACAARYTPASTFKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPVKAAAYDLAENLFEVGEASGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK	98.55	gnl|BL_ORD_ID|2514|hsp_num:0	3524			573	795	cloxacillin; oxacillin; cefalotin
BGC0000875.1|Caprazamycin_9 # 6643 # 7344 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.701	BGC0000875.1|Caprazamycin_9 	6643	7344	+	Loose	500	28.1054	OXA-726	29.17	3005931	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGTCTTCCGTCATCATCGCCATGGCCGGGGAGGGCACACGGTTCGGGGCGCCCTACCCCAAGGAACTGCATGCCGTGAGTCCGCACCGCACCGTGCTGCACTGCTGCGTCGCGCCACTGTCCGGGCTCGATCTGACGCAGGTGCGGATCATCGGCGTCGTCGGCGCCGGCCGGGCCCGGTCGATGGACGTGATCGGGGACGCACTGGGCAAGCGGGGCGCGGACGTGGTGTTCACCGTGCAGAACCCGCAGGGGCACGGGCCCGGCTTGCAGGGCGCCGTCCGCGCCGGCCTGCCGTTCTGCGAGGGAGTGACCGCCGTGCTACTCGCGGACCAGATCTTCACCACCAGGAAACCCGACGACCTCGCGGAGGCGATGGATGCGGCGCGGCAGCACGGACGGTCGGCACTGGTGTACCCGACGACCGACCCCGAGGTGCTGCGCGCCGACGGCGCGGTGGCGTTCGACCGGCGCACCGGCGTCATCAAGGCCTGCGCGGAGAAGCCGCAGAAAGACCTCGACAGGTTCGACGGGCTGTGGGTGGTCCCGATGGTCTCTCCCGAGCACCGGGAATTACTGCCGATGATCGCCACCGATCCCGCCCCGGTCCTGTCCGGCGCGAGGTACGTCGAGGTCGACAGCTACGTCAACGTGACGCGGCCGTCCGACGTCTGGGGCTGGCGATGCCCGGAATCCTGA	MKSSVIIAMAGEGTRFGAPYPKELHAVSPHRTVLHCCVAPLSGLDLTQVRIIGVVGAGRARSMDVIGDALGKRGADVVFTVQNPQGHGPGLQGAVRAGLPFCEGVTAVLLADQIFTTRKPDDLAEAMDAARQHGRSALVYPTTDPEVLRADGAVAFDRRTGVIKACAEKPQKDLDRFDGLWVVPMVSPEHRELLPMIATDPAPVLSGARYVEVDSYVNVTRPSDVWGWRCPES	MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLQYTANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASLKAKEEVLAALPAKLKTL	88.26	gnl|BL_ORD_ID|3966|hsp_num:0	5036			564	690	cloxacillin; oxacillin; cefalotin
BGC0000875.1|Caprazamycin_11 # 8447 # 9748 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000875.1|Caprazamycin_11 	8447	9748	+	Loose	500	27.335	CTX-M-180	36.17	3005603	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGGATCGCGAAGGGGAGCTGGGGACGATGAATCACGGGGAACAGGCAGCTTCAGCTCTGGGGCGCCCCTGGCGGGCCCCCCGCGACCACTCGGGTCCGACGTTCGTCACGGCACGCGGCGCGTGGCTGGCCGACCGTGAGGGACATCGAGTGATCGACGCGACTTCGGGCGCACTGAACGTGTTCTGCGGACACGGGGTCGAGTCGATCGTGGACGCCTATCTGTCGCAGCTGCGGACTCTGGCACACGTCGACATGTCCCAGGGACTCGCGGAGCCCGCGCACCTGCTCGCGGAACGGCTGCGGGACATCCCCGGGCACGGCGGTGACCGCTTCTTCTTCGCCAACAGCGGTTCGGAGGCGATCGAACTCGCCGTCAAGATCTCCTCGCTGTACTGGGTCGCCGTCGACAGCCGGCGCACGGACATCGTCACCTTCGAGCGCGGCTACCACGGCTCGACCTCGCTGTGCCAGTCGCTGTCCGGCCTGCCGCAGACCGGCACCACACCGGACCGGTGCGGTTCGGGCGTCCACCGCCTGGGCTTCGGCGAGTTCACCGGCGCGGGGCAACGCTCGTCCGAGGCGCGTGAGCACATCGCGGAGCAACTGCGGACCATGCTGGCCGATACGGCCGCGGGCACCGTGCTCGTGGAGCCGTTCCTGAACGTCGGCGGCGGCATCCGGCTGCCCGAGGGACTGCTCGCCGACATCCGCCGCATCTGCGACGAGTACGGGACGCTGCTGGTGCTGGACGAGGTGTTCACCGGCCTCGGCAGGACGGGGGCGTGGTTCGCACAGGAGCACGACGGCGTCCGCGCCGACCTGACGGCCTTCAGCAAGGGCCTGACCAACGGCGTGTGCGCGCTGTCCGCGGTCGCGGTCGGCAGCGGGCTGCTCGAGCGGCTTCCCGCCGGCGGCATCGTCTCGTACGGCCACACCATGTCGGCCTCGGCCGCGGCCTGTACGGCGGCGAGCGCGACGCTGGAGTACATGCGCCGGACCGGGGCCGTCGACGCGGCCGCCGGCATCGGCCGCAGACTCCTCGGTGAGCTCGGCCGGGCCCTGCACGGCACCGACGGTGTGCTCGACGTGCGCGGACACGGCTTGGCGCTGAGCGTCGAATTCGACAGTGCCGACACCGCCGAGAGTGTTCAGCAGGTGGCGTATGACCTCGGCGCGTACACCCGGCAGCAGGGCGGCACCGTCATGCTCGCGCCCCCCGCGTGTCTGAGCGGCGAGGAGGAGGACCGGCTCGCCGACCACGTGGTCACCGCGGTCCGCAAGGTGGTCGCAGCGCAGTGA	MDREGELGTMNHGEQAASALGRPWRAPRDHSGPTFVTARGAWLADREGHRVIDATSGALNVFCGHGVESIVDAYLSQLRTLAHVDMSQGLAEPAHLLAERLRDIPGHGGDRFFFANSGSEAIELAVKISSLYWVAVDSRRTDIVTFERGYHGSTSLCQSLSGLPQTGTTPDRCGSGVHRLGFGEFTGAGQRSSEAREHIAEQLRTMLADTAAGTVLVEPFLNVGGGIRLPEGLLADIRRICDEYGTLLVLDEVFTGLGRTGAWFAQEHDGVRADLTAFSKGLTNGVCALSAVAVGSGLLERLPAGGIVSYGHTMSASAAACTAASATLEYMRRTGAVDAAAGIGRRLLGELGRALHGTDGVLDVRGHGLALSVEFDSADTAESVQQVAYDLGAYTRQQGGTVMLAPPACLSGEEEDRLADHVVTAVRKVVAAQ	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTSAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	148.80	gnl|BL_ORD_ID|3440|hsp_num:0	4509			609	732	
BGC0000875.1|Caprazamycin_13 # 11120 # 12184 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0000875.1|Caprazamycin_13 	11120	12184	+	Loose	400	30.0314	catQ	31.11	3002687	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGTCTGACGGGATCACCGCCCCCGCATCCGGACGACACGTGCGGGAGTACCTGTCAAAGATGCTCCGATGGCACTTCGACGAGGAGACCGGATCGCGGTTCTGGGTCGAGCACCGCGACGCACTGCCCTTCGACCCGGTCACCGACATCCGCACCTTCGACGATCTGCGCCGGTTCCCGTCCCGGGTGAACGAGCTGCGCGAGAGCCGGGTCGAGGACCTGGTGCCGCGGGGACTGGCGGAGGAACCCCCGCCCTACGTGGTGGAGTCCGGCGGCACGACCGGCAGTCCGAAGCGGGCCGTCCTGTCGCACACCAGGATCGAGCAGCTGGTCGACCTGTACTGCGCGTATGCGCCGGAGGCCGCGGGACACACCATGCTTTCGCTGTTCCCGACCGGCCCCCACCTCGCGGGCAACTGGCAGCGGCGGTGGGCACGCCGGCTGGGTGTGCTCTACCTCCAGGTGGACATCGACCCGCGGTGGGTGAAGTCCGGCATCGGCACGGAGCTGCAGGAGCAGTACGCCCAGCACGTCCTGGCACAGGCCCGGGACGTGCTGCGCACCCAGCACGTCGGACATCTGCTGGTGACCCCTCCGCTGCTCCGCCGTATCGCGCGGTCGGAGGAACTGACGGAACTGGTGCGTGCCACGGTACGGGTCATCACCTGGGGCGGCGCGCGCATGACGCGTGAGGAACTGTACGAGTACGCGCAACTGGTCTTCCCGCACACCGACTTCGTCGCCACCTACGCGAGTTCCATCACGGGCACCCGGGCGCTGCTCAGGCGCTCGACGGCCTTCGACGACCTCCCGGTCTTCGACCCGGTCGGCCCGGAGCTGTTCGTCCGAGTGGTCGACCCGCGCACCCGCGAGCCGGTGCCGAACGGCACCCGGGGCCAGGTGCTGATGCACACGCTCACCCGGGACATGTTCCTGCCGAACAACCTGGAACGGGATCTGGCCGTGCGTGTGTCCGGGGGCGAGGACTGGCGGGGCGACTCGCTCGCGGATGTCGTCCCGCTGTCGGAGTTCGAAGGCAGTCGGGTAGTCGAGGGGATCTACTGA	MSDGITAPASGRHVREYLSKMLRWHFDEETGSRFWVEHRDALPFDPVTDIRTFDDLRRFPSRVNELRESRVEDLVPRGLAEEPPPYVVESGGTTGSPKRAVLSHTRIEQLVDLYCAYAPEAAGHTMLSLFPTGPHLAGNWQRRWARRLGVLYLQVDIDPRWVKSGIGTELQEQYAQHVLAQARDVLRTQHVGHLLVTPPLLRRIARSEELTELVRATVRVITWGGARMTREELYEYAQLVFPHTDFVATYASSITGTRALLRRSTAFDDLPVFDPVGPELFVRVVDPRTREPVPNGTRGQVLMHTLTRDMFLPNNLERDLAVRVSGGEDWRGDSLADVVPLSEFEGSRVVEGIY	MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANIEITGLLREIKLKGLKLYPTLIYIITTVVNRHKEFRTCFDQKGKLGYWDSMNPSYTVFHKDNETFSSIWTEYDENFPRFYYNYLEDIRNYSDVLNFMPKTGEPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTLGKYFQQDNKILLPMSVQVHHAVCDGYHISRFFNEAQELASNYETWLGEK	161.64	gnl|BL_ORD_ID|1497|hsp_num:0	1633			270	405	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000875.1|Caprazamycin_14 # 12184 # 13686 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000875.1|Caprazamycin_14 	12184	13686	+	Loose	1500	26.9498	kdpD	34.43	3004047	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	ATGGCGAACGGCCGAGACGGGCAGAAGGTCCCTGTCGTGCGGACGACCACGGCCGGCCGGGTCGGCGGGGTGCAATATCGGCCTTCCGGCTTCTGCGTGTGGCGGGGCATCCCCTACGGCGCGATCCCGGCCGACGGCGGCCGGTTCGCCGGCCCGGTGCGTCCGCACCCTTGGGACCGGGTACGGCCCGCGCTGCGCCACGGCAGCATGTCCTGGCAGCTCCCGCCCGTCTACGACAAGGTCTGCGATGTCATGCGGGAGTTCGACTTCGCCCACACCGCCGATCCGGAACACGAGGACTGCCTCAACCTCAACGTGTACACCCCGGACCCCGGACACGCCGGTCTTCCCGTCCTCGTCTGGTTCCACCCGGGCATGCAGGTCGCCGGGTCGGGAAACATGCCCGGCAGACGCCCGGAGGTGCTCAGCCGCAACCACGGCGTCGTGGTGGTCACCATGAACTTCCGGCTGGGGTGCTGGGGCCATCTCTTCCTCGACGACCTGCTCGGACGTGACACGGCGAACCTGAGGCTGCGGGACCAACTGCTCGCCCTGACCTGGGTGAAGGAGAACATCGCGGCTTTCGGTGGCGACGCCGCCAACGTGACCGTGTTCGGGGAGTCCGCCGGAGCGCGCAACATAGGGTCCCTCCTGGGGTGCCCTGCCGCCGACGGCCTCTTCGAGCGGGCAGCGCTGTACAGCGGCGGATGCGAGAACGTGGTGCCGCGGGAGGAGGCGACCGAGTTCGCCCGCGAGTTCCTCGACTGCGCCGGCCTGACCGGTGCCCCCCAGCGGATCCTCTCCGTCCCGAACGTGCACCTGAAGGTGGCGCACCAGCGTCTGCTCAAGCGGCGCGAGCTCGTGCACTACCGGGACGTCCTGGACGGTGTCCACCTGCCCCGTCTCCCGATCGAGGCCATGAGGGCGGGCACGGTCTCCGGCAAGGTCGACCTCCTGGTGTCCCACACCGCCGACGAGGCCGGTCTGTGGGACCGCCTGATGCCCGGCGGAGCGCGTGTGGTGGCGCAGGGCGCCAGGACCGCGGCGGCGGGAACCGCGGGGTACGAATCCGATCACGTGCGGTTCATCAATGAGGAGCTGTTCCTCCGCCCGGCGCGCGACCTGCTCCGGGCGAAGGCCGCGGCGGGCGGTGGCAGGTGCTGGTACCAGGTGTACGACTACGTCCCCACGGACCACAGCTTCGCCGACGCGGAGCGCGCACTGCACGGAATGGACCTCGCGTCACTGCTGCTCGACGTCTCCGCCCCCGGCGCCGCGTCGGAGAGCGATGTCGCCGTCGCCCGCACCGTCCAATCGGCCCTCGTGGACTTCGCGAGCGGGCGGGTCCCGGCGACCGACGGGCTGACATGGCCCGTGTACGAGAGGGGCGCGGAGCGGCTCGTCCGTATCCGCCGGAGGCCGAGTGTGGACACCGCGGTCTGGCCGCAGGAGGACGACACCGCGGCAGCGGGCCGGTGGAGAGGCGAGGACCACCGGTGGTGA	MANGRDGQKVPVVRTTTAGRVGGVQYRPSGFCVWRGIPYGAIPADGGRFAGPVRPHPWDRVRPALRHGSMSWQLPPVYDKVCDVMREFDFAHTADPEHEDCLNLNVYTPDPGHAGLPVLVWFHPGMQVAGSGNMPGRRPEVLSRNHGVVVVTMNFRLGCWGHLFLDDLLGRDTANLRLRDQLLALTWVKENIAAFGGDAANVTVFGESAGARNIGSLLGCPAADGLFERAALYSGGCENVVPREEATEFAREFLDCAGLTGAPQRILSVPNVHLKVAHQRLLKRRELVHYRDVLDGVHLPRLPIEAMRAGTVSGKVDLLVSHTADEAGLWDRLMPGGARVVAQGARTAAAGTAGYESDHVRFINEELFLRPARDLLRAKAAAGGGRCWYQVYDYVPTDHSFADAERALHGMDLASLLLDVSAPGAASESDVAVARTVQSALVDFASGRVPATDGLTWPVYERGAERLVRIRRRPSVDTAVWPQEDDTAAAGRWRGEDHRW	MSNTESLNIGKKRGSLTIYIGYSPGVGKTFEMLSNAIELFQSNIDIKIGYIEPHQRDETNALAEQLPKIATNFTKHGSHHFQYLDVDRIIKESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYTHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDVFEKNRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKWRDFFNTPLIDHLMSFEHSYKIEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSYIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYSITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITVYVINQSKVIKTIPLQNHIDNTTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILAIDYQSSQVINPYDASILESMLNELSLAVENVSLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISLEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI	56.50	gnl|BL_ORD_ID|4924|hsp_num:0	5918			1887	2055	kanamycin A
BGC0000875.1|Caprazamycin_15 # 13716 # 17399 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0000875.1|Caprazamycin_15 	13716	17399	+	Loose	1100	253.447	tetB(60)	29.68	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGTGCGCCTGCTCGCGTCGTGGGCCGCCGACCGGCGATCGGCGGTCGGCGCCGTGACACTCGCGCTGGCCGGTGCCGGAATCGACCTGGCCGCGCCGCTGGTGATCCGGTCCGTGGTGGACGGACTGTCCGCCGGCCGGTCCGTCGCCGTCGGCGCACTCGTGCTGCTCATCGTCGCCGCCCTCCTCAGGTTCGCCGCCCAGTTCGGCCAGCGCGCGACGGCGAGCCGCATCGCGGTCCGGGTACAGCACGACCTGCGCGTGGCCCTGCTGTCCTCGGTGTGCCGCTACTCGGGCGAGCGGCAGGACGCGCTGCGACGCGGCGAGGTCGTCTCCAGGTCGATCACCGATCTGCAGATCGTCCAGTCACTGCTCGCCCTCGCCCCGCAGGCGGCTGCCGCGGTGCTGCATGTCACCGTGCAGTTGGTGATCATGTTCTTCCTCTCTCCGGTGCTCGCCCTGGCCACGCTGGTCACCATCCCGCTCGCGGGCGCGCTGGTGGTCCGCTCCCGTCGGCGGATCTACGCGGCCACCTGGCTCTCCCAGCAGGCGACCGCCGACCTGACCTCGTTCACGGGGGAAGCGATCGCCGGACTCCCCGTCACCAAGGTCTTCGGGCGTGAGGAGCTGATCGAGCGACGCTTCCTCGACCTGGCCCGCGAACTGTACGGGCGGCGCCAGCGGGTCGCCCGGCTGAACGCCGCGTTCAGCCCGGGCCTGACCGTACTGCCGCAGTTCGCGCTCGTCCTGGTCATCGGGCTCGGCGGAACGATGACCCTGCGCGGTGAGATCAGCGTCGGTACGTTCATCGTGTTCGCCACCTACCTGCTCACCATGACCGGGCTGATCCGGCTGCTGGCCGGAGTCGTCTCCGCGATCGCCCTCGCCAGATCGTCCGCCGAACGGATCCACGCGCTCATCGACAGCGCCGAGCACCGGCCCGACGCGGTCGGCAAGGGCACCGGGACGAACCGCGGCGGGGCAATCGGCATGCTGCTGTCCGACGTGGACCTGACCCTCGGGCCGGACGCACGGTACGTGCTGCGGGGCCTGAACATCGAGGTCAGGCGAGGAGAATGTCTCGGTGTCGCGGGCAAGGCCGGGTCCGGCAAGTCAGTGCTCGGACTGGTGCTGCAGGGGCAGTACCGACCCCGTGCGGGGCGTGTGGCACTCATGGGCGACAGCGTCGAGACCGGCGATGGCACGGAGCCGGTGGCCCTCGGCGACCCGGACGTCGTGCTCGTGACGGAGGAGCCGTTCCTGTTCTCCGGCACCATCCGGCACAACGTCCTCCTCGGCAGGGAGTTCGACGCCGACCGGTACGCGTCGGCCCTCGCCGATGCGGCCGTGGACACGATGCTCGAGCGCCTCGCGGACGGGGACCGGACCTGCGTGGGAGAGAGCGGAGCCAGGCTCTCCGGCGGCGAGCGGCAGCGGATCGCCCTCGCCCGGGCCCTCTACGAGTCACCGGGCCTGCTCGTGCTCGACGACGCCACATCCGCCCTGGACACCCTGACGGAGGCCCGGGTGTTCGACGCGCTGCGACGGCGACTCGGGCGCGGTCGCACCCTGGTGGTCACCGGTCGGCGGCGTGCCGTGCTGTCCCTCGCCGACCGGATCGCGGTCGTCGAGGGCGGCCGCGTCGTCGAGGAGGGGGACGCCCGCACACTGCTGCGTGACTCCGTGCGGCTCAAAGCCCTGCTCGGCGAGGAGACGCCGACCCCGACGCTCGGCGCCGACGAGGTGACCGGTGACGAGCCGCAGGCGCGTGCGGCGCTGCCCGCGAACACCCGACCCGTCGCGGCGACGGCCCTTGAGGCAGACCCGGCCGAGGCGCTCGCACACCATGTCACCGCGCTGCCTCCGGTTGTCGACGAGCCCGTCGGTGCCGATGTCGACAACGGCCGGCGCAGCGGCCCGCTCGTCCTGCGCGAGGTGCTGCTGCCCGTCCGGTCGGCGGCCGTCACGGCGCTCATGTGCATAGGGGTCGAAGTCGTCGCTGCCGTGGCGCTCCCCGCGGTGGCGCGGGCCGTCCTCGGCCGGTCGAAGGACGGTGACGCCACCGCCGTCGGTCTGCTGTTCGTGCTGGGGCTCGTCATCACCGCGGTGAGCTGGATCGCCGGGTGGGGCACGGTTCGCGCGTCCACGCGGGTGTGCGACCGTGTGTTGTTCACCGTCCGCCTGCGGTGTTTCCGCCACATCCAGCGCCTTCCGCTGGACTACGTGGACCGTGTGCGGTCGGGGGGTGTGCTGACCCGGATGACGGCGGACATCGACTCGCTGTCCGCGTTCCTGCAGACCGGCCTGCTGTCCCTGATCATCAACCTGATGCTGGTGTTCGGTGCCGCCCTGGCGGTGGTGCTGATGGCACCCGGATTCTGGCCGGTCCTGGTGGCGGCGGGCCTCGTGGTGCTCGTGGGGACCGCCGCGTTCCGGCGGATCGTCTCCCGGTCGTACCCGCGAGCGAGGGAACTGCTCGCCGCGGTCAACGCCGACCTGTACGAGAAGGTGCACGGAGTCCGCACGGCACAGATCTTCCGCTGCACCGACCGGATCACGGCCGAGTTCGCGAAGAAGTCGGCGGCGTACCGCGACGAACGCCAGGCCGGACAGCGCGCGGTGGCGTGGTTCTTCCCCCTGGTGGCGATGACCATCGACATGGCACTGATCTGCGTGCTGCTGCCGGCCGTGGTGGACGGACTGCCCTGGGCGGCCGGTGACGACGGCGGCACGATCGCCGCACTCATCCTGTACGTGTCCATGCTGTACTACCCGATCCAGCAGATGGCGACGGTCTACGACAGTGCCCAGCAGGCCAAGGTGGGGCTCCGCCGCATCAACGGCCTGCTGTCGGAGCCGACCGAGGGAGCACTCGCCGGTGTGCCGGCCGGTACACCGGGGGCCGGCGGTGCCATCCGCTTCGACCACGTCGGGTTCACCTACCGTCAGGACGCCCCGTACTCGCTCCTGGACGTGGTCCTCGACGTCCGGCCCGGGCAGTCCCTCGCCGTCGTCGGTCCCACGGGCGCCGGGAAGTCGACGATCGTCAAGCTGCTGGCCCGGTTCTACCGGCCGCAGCGGGGGGCGATCCACCTCGATGGCGTGGACATCGCGACGATTCCGCTGCGCGACTACCGCCGACGGGCCGCCATCGTGCCGCAGGAAGCCCATCTGTTCAGCGGCTCCGTCGGCGAGAACATCGCGTTCGGCCGCCCCGATGCCTCCCGGGCGGAGATCATGCGCGCCGTCCGCTCGTTCGGTGCGTCGGAAATGATCAACTCCCTGCCCGGCGGACTGGACTACGACGTCGGACCGCGAGGATCGGCGTTGTCCGCAGGACAGCGGCAGGTGGTCGCCCTGCTGCGGGCCATCGTCTCGGACCCCGACCTCCTGTTGCTGGACGAGGCCACCGGCGCGCTCGACCTGGAGTCGGAGCGGAGCATCGTCAGCGCCCTCCGCGAGGCAAACGGCGGGCGCAAGACCGTCGTGGTCGCCCACCGGCTCGCCACCGCCTCACAGGCCGACGTCATCGCCGTCGTCGAGCGGGGCCGCCTGCTGGAGACGGGAGGACACGAGGCCCTGATGCTGAGATCGGGGGGCCTCTACGCCGGCCTGTGGGCCGCCTCCGAAGCCTCCGGCCACGACGGAGCAACGAGCAACCCAGGACAAGGAGACGAAGCGTGA	MVRLLASWAADRRSAVGAVTLALAGAGIDLAAPLVIRSVVDGLSAGRSVAVGALVLLIVAALLRFAAQFGQRATASRIAVRVQHDLRVALLSSVCRYSGERQDALRRGEVVSRSITDLQIVQSLLALAPQAAAAVLHVTVQLVIMFFLSPVLALATLVTIPLAGALVVRSRRRIYAATWLSQQATADLTSFTGEAIAGLPVTKVFGREELIERRFLDLARELYGRRQRVARLNAAFSPGLTVLPQFALVLVIGLGGTMTLRGEISVGTFIVFATYLLTMTGLIRLLAGVVSAIALARSSAERIHALIDSAEHRPDAVGKGTGTNRGGAIGMLLSDVDLTLGPDARYVLRGLNIEVRRGECLGVAGKAGSGKSVLGLVLQGQYRPRAGRVALMGDSVETGDGTEPVALGDPDVVLVTEEPFLFSGTIRHNVLLGREFDADRYASALADAAVDTMLERLADGDRTCVGESGARLSGGERQRIALARALYESPGLLVLDDATSALDTLTEARVFDALRRRLGRGRTLVVTGRRRAVLSLADRIAVVEGGRVVEEGDARTLLRDSVRLKALLGEETPTPTLGADEVTGDEPQARAALPANTRPVAATALEADPAEALAHHVTALPPVVDEPVGADVDNGRRSGPLVLREVLLPVRSAAVTALMCIGVEVVAAVALPAVARAVLGRSKDGDATAVGLLFVLGLVITAVSWIAGWGTVRASTRVCDRVLFTVRLRCFRHIQRLPLDYVDRVRSGGVLTRMTADIDSLSAFLQTGLLSLIINLMLVFGAALAVVLMAPGFWPVLVAAGLVVLVGTAAFRRIVSRSYPRARELLAAVNADLYEKVHGVRTAQIFRCTDRITAEFAKKSAAYRDERQAGQRAVAWFFPLVAMTIDMALICVLLPAVVDGLPWAAGDDGGTIAALILYVSMLYYPIQQMATVYDSAQQAKVGLRRINGLLSEPTEGALAGVPAGTPGAGGAIRFDHVGFTYRQDAPYSLLDVVLDVRPGQSLAVVGPTGAGKSTIVKLLARFYRPQRGAIHLDGVDIATIPLRDYRRRAAIVPQEAHLFSGSVGENIAFGRPDASRAEIMRAVRSFGASEMINSLPGGLDYDVGPRGSALSAGQRQVVALLRAIVSDPDLLLLDEATGALDLESERSIVSALREANGGRKTVVVAHRLATASQADVIAVVERGRLLETGGHEALMLRSGGLYAGLWAASEASGHDGATSNPGQGDEA	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	211.92	gnl|BL_ORD_ID|2307|hsp_num:0	2646			42	1725	tetracycline
BGC0000875.1|Caprazamycin_16 # 17405 # 18430 # 1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.669	BGC0000875.1|Caprazamycin_16 	17405	18430	+	Loose	400	30.8018	Erm(44)v	23.85	3003971	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	TTGACGCACGGCGAGGAGTTCAGGTTCAACGGGGCGGTCTCGTTGCAGCAGGGCGAGAACTGGATCGCCCCGTGGCGGGTGCCTTTCGACGAGGCGCGCCTGTACTTCCCGGAAGGGGGCATAGGGCGGGCCGCGATGCCGTCCGGGGTGTCCGTGGCGCTGATGACGGACGCGGGGCACCTCGAACTGGACTACCTGTGTTCGCGGTGCCCCGACAACATCATCGAACTCGCCGAGGACGTACAGCAGCTGGAATCCGTCGACGTCGTCGTGGACGGCCGCCGGGTAGCCCGGCACGCCCTGTGTGCCCTGAAGACCGAGGAGACCCTGCGACTCGACCTCGAGAACGAGAGCGGCGGCAGCAGGCTGGTCGAGATCTGGTTGCCGATCTACGCCCAGTTCCGTTTGATCGACCTGCGGATCGAACAGGGCGCGACCGCGTCGTCGCCGGCCCCGAACCCGAGGCGGTGGGTGCACTACGGCGGCTCCCTGTCGCAGGGGATGGGGGCCGACTCCCCGCTGACCAACTACGTCCAGTCGAGCAGGTGGCGCGGCGACCTCGATCTGGTGTCGGTGGCTCGGGGCAAAGGCACGCACATGGAGCCGGTGTTCGCGGATCTGATCGCCGGTCTGCGGCCGCGGTACGTGACCATGGCGGTCGGAGGAATGGTCTACCTCACCGGATCCCTGAACCAGTACACCTACCTCACCAACATGCTCGGTTTCGTCAAACGCATCGTCGACACGGCGCCCGACTGCGAAGTGGTCGTCCTCGTACCGCCGATGAGTCCTCGCTACCGAGACCACAAAGGCCCGAACGGGATGACCGCGGCGGAAATGCTCGAGACGCACTACGCGACCGTTCAGACGGTCATGAAGTGGGGCGACCGGAGGGTCCACCACGTGCCCCAGTGGGGGGACGTCGACGAGTCCGACTTCCTCGCCGACGGCATCCATCTGACGTCGAGCGCGCACCGCCGCTACGGGGAGTACCTGGCGCAGGGCATCCGGAAGTGCCTCGGATGA	MTHGEEFRFNGAVSLQQGENWIAPWRVPFDEARLYFPEGGIGRAAMPSGVSVALMTDAGHLELDYLCSRCPDNIIELAEDVQQLESVDVVVDGRRVARHALCALKTEETLRLDLENESGGSRLVEIWLPIYAQFRLIDLRIEQGATASSPAPNPRRWVHYGGSLSQGMGADSPLTNYVQSSRWRGDLDLVSVARGKGTHMEPVFADLIAGLRPRYVTMAVGGMVYLTGSLNQYTYLTNMLGFVKRIVDTAPDCEVVVLVPPMSPRYRDHKGPNGMTAAEMLETHYATVQTVMKWGDRRVHHVPQWGDVDESDFLADGIHLTSSAHRRYGEYLAQGIRKCLG	MNNKNPKNSQNFITSQKHINEILNETNIGIDDNIIEIGTGKGHFTKYMSNIARFITSIEIDKALYCNLKNDISLSTNIELVNKDILIYEFPKYKQYKVFGSIPYNISTEIVKKILYESNAEYNYLIVEFGFAKRIMDKKRALALLLLPKIDIEILKVIPNSYFHPKPKVDSALILLKQHKSLISKNDENAYHFFVYKWINKEYKQLFTKNQFNKALKHAKVQNINEISKEQFISIFHSYKLFN	140.33	gnl|BL_ORD_ID|4706|hsp_num:0	2445			222	594	erythromycin; clindamycin
BGC0000875.1|Caprazamycin_17 # 18492 # 18698 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000875.1|Caprazamycin_17 	18492	18698	+	Loose	500	26.1794	OXA-159	36.36	3001464	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCAGGACGCAGAGCACGTACAAGGTGACGAGCCGACCGAGCCGACCGAGCCGACCCGTTCGGTCACACCGGCGGAGGAGGCCGAGCCGGCCGGAACGGCCGGGAAGGCGGCCGCGGAGGACCTCGACTGGTTCGAGGACGTACCCGAGGAGAACGTCGGTGCCGTGCTGTCGCTGGACGAAACAGCCCCGCTCCCGTGGATCTAG	MQDAEHVQGDEPTEPTEPTRSVTPAEEAEPAGTAGKAAAEDLDWFEDVPEENVGAVLSLDETAPLPWI	MKKTLSRWRRGALALRLLGALASPVVFAMPGHAAEPAHSSAVRIAERADWGKYFADEGVKGTVIVLDGRTQTYQAYDAARAERRMSPASTYKIFNSLLALESGALDNEREVIPWDGKPRRVKAWNAALDLRNAFRVSCLPCYQVVSHKIPRQYAQAKLNEAGYGNRTIGRAAHAYWIDDSLQISAREQVDFLQRLATGALPFSARSQDIVRNISIVEANVDYVLHGKTGWFTEKKPDIGWWVGWLERDGNLTMIALNIDIQTDADAPKRARIVRNVLKDLKLI	24.03	gnl|BL_ORD_ID|3754|hsp_num:0	4824			69	201	cloxacillin; oxacillin; cefalotin
BGC0000875.1|Caprazamycin_18 # 18727 # 20562 # -1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0000875.1|Caprazamycin_18 	18727	20562	-	Loose	900	26.9498	MdtK	29.41	3001327	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	GTGACTTCCTTCCAGTTCGGCTTACGGCCAGCAGGGCGCCTGGGCGCGTGTCAGGGGGGCGGAGAGGCGAGCAGTTCGGCCGTCGGCACGGTCGCTCGCGCGAACCAGATCGAGAATCCGGACACCACCAGCGCCCGCACCCGCAACGAGGGGCCGGAGCCACTCGGGTCGCAGCGCATGCGCGCCTCGTCCCCTGCCGCGATCTCGTGCACGCTCCTGGTGTGCAGGCTCCCGGCACTGTCGTCGATGTCGATGAGCACCCGGGCACCCGGGTCCGTCCGTCGTCTCCCGAAGAACCGGACGCCGACGCTCCCCGGGGCCGGTACCGTGATCAGCGGGAAGCGGTCTCCGTCAGGTGATTTCGCCAGGTGTCCGCAGACGTCGCACTGCGCCCAGTGGCTCTCTCGGTCACTCGCCACATCACTGGCGGTGACCACGTACGCCGGGAGCCCGCACAGCCGGCAAGCACAGAGCTCCCCCGGCCTTTTCGACCCGAACAGCAGTCCGCTTCTCATGGCGCGTTCGATGGCGCGGGCGCCGATGGCCGGAACCGTCCCCACGAAGCCCAGCAGGTCCTGCTCGAACCGGTCGGCGAGAGCGGTGATGCCGGCGAGGCACCGGGTGACCTCGGCCCGGGCGGTCCCGTCGTACAGATTCCGTTCGTTCGCCCCCGACAGCGCTCTCGCGGCCCGGGCCGCCCAGCCCGACGCGCTGTCGATCCGGGCTGTGCAGGCGTCCAGCGCCGCGCGCGCGGCGGGGCCGCCCGCCAGGCGCAGGGAGGTGACCGCCGCACGCGCGTCGTCGAGGGTGCGCGTCAGCGCCCGCAATCGCGCGCGGTCCTCGGACCAGGGCACCCGGCCGGAAGCAGCGGCGTGGAGTTCGGCCCGCAGCCCGGTGACGGCTGTCCCCCGGTCGAGGACGGCGTCGGTGTACCTCAGCAGGACCGGGTCGCCCAGGCACAGGGTCCCCGCCGACGGATCGCCTCCGCCCGGAGCGGACCCGGCCAGTTGGTGCAGCTCATGGACGACGATGGCTTCGCGGGACGTCGGCATGCGATACAGCGACCCGCACACCGTCGCCGCGTACGAACTCGCGAAGGAGTCGACGAAGTTGGACGCGGGCACACTCCGGCGCCAGTCGGGTAGCAGCGCTCCGCAGGATCCCAAGTGGATCCACACGCAGCGGATCTCGTCGAGCCTGCACAGTCTGAGACCGTGCTCGGCGCACATGCAGTCCTGCTCGGGCGACCGGCTCGCGCTGTGCGAGCAGATGAACCCGTCCCCGATCTTGATGTGGGACTCGTTGCCGTGTCCGTACACGGAGACGCTGTGCACGTCCTGCGTCCCGAGGCCCGTGAACTGGGCCGCGTCGCCCACGACGGACGTCGAATCGGCGGCATCGACGACGACGTGTTTGCCGGCCCGCACCCGCCGTGCCAAAGCCATGCGCTTCAGCATGAAGCCCAGTTCCCCGGCGGAGCGGGCCGGCAGCGTTCCCACCGGCAGGCCCATCCGGCGCCCGAACTCCACGATGTCGCGGGCGAGTCGGAGGTCGAACGCCTCGCGGGCGGCGACCACCAGGACGTATCGCGCCGACGCCGGTACGGACCGCTGGGCGGCGCCGCCGAGCAGGTCCTTGGGGGAGGCCTGCGTGACCGTGCCGCAGCCGAGCGCGGCGAGGTCGTCGTCGTCCGGGAGGAGATCACTTTCCAGGACGACCACCGCGCCCTCGGGCCATGTCCGGCCGGCCTCGGACCCGCTCGACCGCGAGGCATACCACTGCAGCACGTCCCGCTGTCTGTCCTCGACCTCGACGTCGACCACGGCTGAGAGCTGA	MTSFQFGLRPAGRLGACQGGGEASSSAVGTVARANQIENPDTTSARTRNEGPEPLGSQRMRASSPAAISCTLLVCRLPALSSMSMSTRAPGSVRRLPKNRTPTLPGAGTVISGKRSPSGDFARCPQTSHCAQWLSRSLATSLAVTTYAGSPHSRQAQSSPGLFDPNSSPLLMARSMARAPMAGTVPTKPSRSCSNRSARAVMPARHRVTSARAVPSYRFRSFAPDSALAARAAQPDALSIRAVQASSAARAAGPPARRREVTAARASSRVRVSARNRARSSDQGTRPEAAAWSSARSPVTAVPRSRTASVYLSRTGSPRHRVPADGSPPPGADPASWCSSWTTMASRDVGMRYSDPHTVAAYELAKESTKLDAGTLRRQSGSSAPQDPKWIHTQRISSSLHSLRPCSAHMQSCSGDRLALCEQMNPSPILMWDSLPCPYTETLCTSCVPRPVNWAASPTTDVESAASTTTCLPARTRRAKAMRFSMKPSSPAERAGSVPTGRPIRRPNSTMSRASRRSNASRAATTRTYRADAGTDRWAAPPSRSLGEACVTVPQPSAARSSSSGRRSLSRTTTAPSGHVRPASDPLDREAYHCSTSRCLSSTSTSTTAES	MNVSTALRQAVVRTPWYAKRKSYKVLFWREITPLAIPIFLENTCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAVVLAVVIHYFGSEIINIVAGEATPEVKGLALTYLELTVLSYPAAAIALIGSGALRGAGNTKIPLMINGGMNILNIIISSILIYGAFSWQGLGFAGAGLGLTISRYIGAVAIIWVLMIGFNPALRIPLKSYLKPLNFGIIWEVMGIGIPASIESVLFNGSKLLTQMFVAGMGTNVIAGNFIAFSVAALINLPGNALGSASTIITGKRLGTGQIGQAERQLRHVFWMSTIVLTAIAWGTAPFAGLFASFYTQEQDVKEVVKVLLWLNAAFMPIWAAAWVLPSGFKGARDVRFAMWVSMLGMWGCRVVAGYTLGIVLGMGVVGVWLGMFLDWAVRGALFYWRLISGRWLWRYPRVKRE	128.90	gnl|BL_ORD_ID|1650|hsp_num:0	1752			912	1107	ciprofloxacin
BGC0000875.1|Caprazamycin_19 # 20559 # 20735 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000875.1|Caprazamycin_19 	20559	20735	-	Loose	50	25.7942	vanW gene in vanI cluster	42.86	3003724	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	GTGGTTCAGGGACGCCGCCCGGACTCTGACCCGCACCCAGCCCTGAGGCACCTCGGGATCGGGGCGGTGTCCGACGACGACGGCGGACAGGGGATCGTCCGGATCGGGGGCGGTCGCGAACACTGCCTTCATGAGTCGTCGTCCTCGGGCTGCCGGATGGCGTTCCCACGCATGTGA	MVQGRRPDSDPHPALRHLGIGAVSDDDGGQGIVRIGGGREHCLHESSSSGCRMAFPRM	MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK	15.55	gnl|BL_ORD_ID|4746|hsp_num:0	2242			741	825	vancomycin; teicoplanin
BGC0000875.1|Caprazamycin_21 # 21682 # 22935 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.710	BGC0000875.1|Caprazamycin_21 	21682	22935	+	Loose	400	32.3426	Erm(43)	20.69	3003205	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAGTGATCCCTGACAGGTGGCGGGCGAGGAGCGCGATCGATCTCGTGCGCGAGGCAGGGGACGGCGCCGACCTGCCGCCGTGTGACAGCAGGTTCCACTACGTTCCGCCGTGGCGGTCCGAAGCTCTGGAAACACTGGCCGAGAAGGTGGTGCCCGCCGTCGCCGGCATCGCGGCGCGGTACGCGGCCGCCGGCCGGCCGGACGACCTGATCACGGCGGACGAGACGGCGACACTGGTCGGCGCGTGTGCATACGTACGGCTGCGCGGCGACGGTGACGGCTGCACCCTCGCCTTCGGCGGCCTGCCCTCGGAACTGACCGGGCACGCGCAGCATGACCGGATGACCGTCCGCGCGGCCCTGGAGTGCGTCGGCTGGTTCGACGCGAACCAGCGCCTCCTCACCGCCACCGGCATCACACCGGGGCGGCCCGGTGGAACGGCGGCTGCCGACGGCGCGCTCTACGGACCGGAGCTGGCACGCCGCTACGACCCGGCGCGGCAGGTGACCGAGCAGTTCAACGACGTGCTGCGGGGATTCGCCAAGGAGTTCCTCGGGATGCGCCGCGTCCTGGAACTGGGCACCGGCACCGGTCGAGTGGCACGTAACATCGCCCCTTTCGCCGGCTCCTACGTGGGGATCGAGGCCTCCCGCGCGATGATCGACGCCGGACGCCGGGACGGCTTGGACGTACGGCAGGGGGACATGATGGCGATGCCGTTCGAGACGGGGTCGGTCGACGTGGTCGTCGAGCACGAGAGTGTCGACTTCTGCACGGAGCCGCTGCTGGCCGCCACCGAGATCGAACGGGTACTGGCCCTGGGCGGGCAGTTCTACCGGATCGAGCTGGAGACCGTGCCGGCCGCCGGCATCACCCGACTCCAGGACGAGATCACCGCGCGGCTGGCGAAACTCTCCGGCGGAGTCTTCCCCTACTGGACCAAGGGACAGCGCCGGCGCCTGCACAGCCGGCTGACGGGCCGCGGCTTCGCACACCGCAGGATCCGGCTCGCGCGGTGGCACGAGACGCGGACCCTGCGCAACTGGCTCCAGGGCCTGGTCAACGCGAGCTATCCGTCGTTCTCGGGCGTCGACGAAGAGACGGCGTCGTCCACCTGTGTGGAACTGGCCCGCGCGGCGTCGATGGGGGACCTCGACACGAAGTGGCCGGGAGAAGCCGGCGTGGTGGTGCATCAGTACGAGGCCGTCGAGTGGTGCTGCGCCGCACACCGCCCCCGGCCGACCACGTGA	MTVIPDRWRARSAIDLVREAGDGADLPPCDSRFHYVPPWRSEALETLAEKVVPAVAGIAARYAAAGRPDDLITADETATLVGACAYVRLRGDGDGCTLAFGGLPSELTGHAQHDRMTVRAALECVGWFDANQRLLTATGITPGRPGGTAAADGALYGPELARRYDPARQVTEQFNDVLRGFAKEFLGMRRVLELGTGTGRVARNIAPFAGSYVGIEASRAMIDAGRRDGLDVRQGDMMAMPFETGSVDVVVEHESVDFCTEPLLAATEIERVLALGGQFYRIELETVPAAGITRLQDEITARLAKLSGGVFPYWTKGQRRRLHSRLTGRGFAHRRIRLARWHETRTLRNWLQGLVNASYPSFSGVDEETASSTCVELARAASMGDLDTKWPGEAGVVVHQYEAVEWCCAAHRPRPTT	MNNKNPKDTQNFITSKKCINEILKNIIITADDNIVEIGTGKGHFTKALSKVVKSVIGVEIDKSLYYNLKKDSKLQDNIQLINQDILNFQFPDNKDYKIFGSIPYNISTEIIKKILYESKAEYNYLIVELGFAKRIQDKNKALSLLLLPKMDVEILKVIPNKYFHPKPKVESALILLKKHKPLISAKDEKNYQFFVYKWVNKEYKKLFTKNQFKKALKNANVQNLNKISKQQFISIFYSYKLFN	171.60	gnl|BL_ORD_ID|1422|hsp_num:0	1546			96	270	erythromycin; clindamycin; pristinamycin IA
BGC0000875.1|Caprazamycin_22 # 22899 # 23510 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0000875.1|Caprazamycin_22 	22899	23510	+	Loose	375	84.7297	tmrB	32.78	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	GTGCTGCGCCGCACACCGCCCCCGGCCGACCACGTGACCAGGACGGAGAAGCCCTTGCTGGTGTGGATCAACGGTCCCTTCGGGGCCGGCAAGTCGACCGTCACCGACGAGCTGTCACGGGCCGCCGGCGAGGTCATCGTCTTCGATCCCGAAGAAGTCGGCTTCCACCTGCGCACATGGGTTCCGTTGCCGGCATCGGGGGACTTCCAGGACCTCGCGTGCTGGCGCGATGTCGTCGGGCAGACGTGTGCGGCGTTCGCCCGGCACTACCCGTCCCGTCTTCTCCTCGTGCCGATGACCGTGGTGAACGACGACTACCGGCAGGAGATCTTCGACATCATCCGCAAGAGCACGGACCAGGTCCTGCACGTCTGGCTGTCCGTCACCCGGCAGACGCTCGCCGACCGCATCACCCACCAGGTCATCTGGCCGGACGACCCCGAGCGGGACGCCGAGGTACGGGCCTGGCGACTCGCGCAGATCGACGGCGCGATGACCGCCGAGAGCCGACTCGGCGCGGACACCGTCGTCCTGCCCACCGACGACACGCGTCCTCGGCAACTGGCGGAACGGATCCTCGCCGAAGCCGCGCGGCGCACCGGAAAGGCCTGA	MLRRTPPPADHVTRTEKPLLVWINGPFGAGKSTVTDELSRAAGEVIVFDPEEVGFHLRTWVPLPASGDFQDLACWRDVVGQTCAAFARHYPSRLLLVPMTVVNDDYRQEIFDIIRKSTDQVLHVWLSVTRQTLADRITHQVIWPDDPERDAEVRAWRLAQIDGAMTAESRLGADTVVLPTDDTRPRQLAERILAEAARRTGKA	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	103.05	gnl|BL_ORD_ID|1654|hsp_num:0	1794			0	504	tunicamycin
BGC0000875.1|Caprazamycin_23 # 23582 # 24781 # 1 # ID=1_23;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0000875.1|Caprazamycin_23 	23582	24781	+	Loose	770	26.1794	tet(J)	35.0	3000177	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGCTGAAGATGGCCGTGTGGAAAGACATCGAATTCCTGGACCGGTTGATCGTCGCCGCGGGCGGAGACGAACGAGGCCTCGTGGAGATCACGAAGAACCTCCCGCTGGACGAACTCACCTCGGTCCTGGTCGACGAGATCGTGTTCCGGGCGAACACCAACGCCGCCGGCTCGGCGTTCCGCCGGGAAGAGGCCCAGGTGCCGGAAATCGGCACCGTGCTCCTCGGGGTGCATCACGACGGCCTCACGCAGGAGCGGGCGCTCGGCGTACGGGCCGACGGCACGGTCGAGCAGACCACCGGGACGAGGGGCGACATCGCCCTGCGCCTCGACTACGACTTGCACGACCTCATCCGGGTGCTGTTCGGGCCGACGCGCCTCAGGCCGGCCGGTACCTACTCCTCGGCCTTCCTCCCGGCCACCGCAGGCCATCAGCGGATGCCCCCGCTCGAAACCGTCTACCAGGGCATGGAGGTCGCGGGAACCGTGCTGTCCGGGCTGTCCCAGCACCACCCCGACCTCAGCGAACTGGCCAGACGCTACCGGACCGACAAGTGGGGCGGGCTGCACTGGTTCACGGGGCTGTACGAGCGCCACCTGCGGGAGTTCCGGGAACTGCCGGTGCGGATCCTGGAGATCGGCATCGGCGGCTACGGCAACGCCACGCTCGGTGGCGAGTCACTGCGCATGTGGAAACGCTACTTCCCGCGTGGTCTCGTCTTCGGCGTCGACATCTTCGACAAGTCCGCGGTCGACGAGCAGCGGATCACCACCCTGCGCGCGGACCAGAACGACCCGCAGGCCCTCATCGAGGTCGAGGAGAAGTACGGCCCCTTCGACCTCGTCATCGACGACGGCAGCCATGTGAACGGCCACGTCCGCACCTCGCTCGAGACGCTCTTCCCCAGACTGCGTGCCGGAGGCCTCTACGTGATCGAGGACCTCTGGACGTCGTACTGCCCCGGTTACGGCGGTCAGGACCGGGTTCCCGTGGACCGGACGACCTCGGTGGGGATGCTCAAGGACATCGTGGAGGGCATCCAGTACGAGGAGCAGCCCCGGCCGCCCGGCCGGCCGCCGGCCCATCTGGAGCGGAACGTGGTCGGCGCACACGTCTATCACAACCTCGCGTTCCTGGAAAAGGGCGTCAACGCCGAGGGAGGGGTCCCGTCGTGGGTGCCCCGCCATCCGAGGTACTGA	MLKMAVWKDIEFLDRLIVAAGGDERGLVEITKNLPLDELTSVLVDEIVFRANTNAAGSAFRREEAQVPEIGTVLLGVHHDGLTQERALGVRADGTVEQTTGTRGDIALRLDYDLHDLIRVLFGPTRLRPAGTYSSAFLPATAGHQRMPPLETVYQGMEVAGTVLSGLSQHHPDLSELARRYRTDKWGGLHWFTGLYERHLREFRELPVRILEIGIGGYGNATLGGESLRMWKRYFPRGLVFGVDIFDKSAVDEQRITTLRADQNDPQALIEVEEKYGPFDLVIDDGSHVNGHVRTSLETLFPRLRAGGLYVIEDLWTSYCPGYGGQDRVPVDRTTSVGMLKDIVEGIQYEEQPRPPGRPPAHLERNVVGAHVYHNLAFLEKGVNAEGGVPSWVPRHPRY	MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPILGKLSDKYGRKPILLISLLGAALDYLLMACPTSLWMLYIGRIIAGITGATGAVCASAMTDVTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQETQTTKISTEISALNQDTAPHSTTGFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRFAWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVWVMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSYSVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS	100.25	gnl|BL_ORD_ID|1040|hsp_num:0	988			1005	1119	tetracycline
BGC0000875.1|Caprazamycin_24 # 24825 # 25622 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.684	BGC0000875.1|Caprazamycin_24 	24825	25622	+	Loose	900	27.7202	tet(O/W)	29.09	3007121	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGACAACCGCTGGACCCGCGACCGCCCACGACAACGCCGCGGACGCCTACCTCGACCTGCTGAAACGCTGCCTGACCCGATACGACGGCCATCAGATCTTCCTGGGCCCGCCGCTGGCGAAGCCCCGCACGATGGAGCAGATCGAGCGGGGCCGGTTCGCACACCAGGACGCCGACACCATGGTCGGCTGGCCGCGCCTGGACAACGTCCGCCACTGCGTGGAGACCGTGCTCCGGGAACAGGTCCCGGGCGACCTGCTCGAAGCGGGCGTGTGGCGGGGCGGTTGCTGCGTCTACATGCGCGGCATCCTCAAAGCCCGGGCTGTCGACGACCGCACGGTGTGGGTGGCCGACTCGTTCGCGGGGTTCCCCGAGCCGGACATCGACCGGTACCCGGACGACTCCGTCTACGACAGCCCCGTCGCGCGGGAGATCCTCGACGGCTTCGGATACCCGATCGCCATCAGCCTGGACGAGGTGAAGTCCCGGTTCAGGTCCTACGGGCTGCTGGACAGCCAGGTCCGCTTCCTCGCCGGGTACTTCGCGGACACACTGCCGCAGGCCCCCGTGGAGCGGCTGGCCGTTCTGCGGCTGGACGGCGACATGTACCAGTCGACACTGGAGTCGCTGGAGCACCTGTACCCGAAGCTGTCCGCCGGGGGCTACTGCATCATCGACGACTACTCGCTGGAGGGCTGTCGCAAGGCCGTCGAGCACTTCCGCGAGGCGCACGGGATAGGGGAGCCGATCGAGAAGATCGACTGGACGGGCGTCTTCTGGCGCAGGACGTCCGCATGA	MTTAGPATAHDNAADAYLDLLKRCLTRYDGHQIFLGPPLAKPRTMEQIERGRFAHQDADTMVGWPRLDNVRHCVETVLREQVPGDLLEAGVWRGGCCVYMRGILKARAVDDRTVWVADSFAGFPEPDIDRYPDDSVYDSPVAREILDGFGYPIAISLDEVKSRFRSYGLLDSQVRFLAGYFADTLPQAPVERLAVLRLDGDMYQSTLESLEHLYPKLSAGGYCIIDDYSLEGCRKAVEHFREAHGIGEPIEKIDWTGVFWRRTSA	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQPIGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQSVCLTELKGYQAAVGQPVIQPRRPNNRLDKVRHMFQKVM	41.47	gnl|BL_ORD_ID|4795|hsp_num:0	5791			1806	1917	tetracycline
BGC0000875.1|Caprazamycin_25 # 25619 # 26878 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0000875.1|Caprazamycin_25 	25619	26878	+	Loose	600	29.261	TriB	27.27	3003680	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGGGAGCGCTGCGAGGCCCGCGTGCAGAGGCGTCTTCGGTGGACAGCACCGTCGCCCGGGTGATCTCGGCGGCAGGCTGCAGGGACGAGGAGATCACGTCGGTCATCGAATCCGCGGGACCCGAGAGGGTCGCCGGAATCCTGGTGGACGAGATCGTGTGCAGAGCGGACCTGCCGCCCGTCGAACTCGGCGAGGGAGTCGTCGTGCAGTTGCTCTTCGGACACGGGACCAGGACCATCTCCCATCTCGTGCAGGCAGGACCCGCCGGTGTCACGTACGAGCCGGGTGGTGCGGAGAGTCCGCACGCCCGGATCGAGCAGGACCTGTGTGAGGCGGTGCGCGCTGTCTTCGGGCCGCACGGCGATCGCGCGGCGGCGACCAGACGGCTGGAGCTGCGGGGATCAGACACGCCGCAGGCTTACGTGCTGCCACCGACGGCGTTCTGGGTGGCCCAACGGCTGCTCGCCACCATGGACGACCGCGACGAGATCGGGCTGACCGAACTGGCCAGCCGGTACGGCTCGGACAAATGGGGGATCCACCGGTACACACAGCACTACCAGCACCACTTCGCGCCGCTGCGCGATCGACCGCTGACCGTCCTGGAGATCGGTGTCGGGGGCCTCAGCGGCGGCACCACCGGCTACCGTGCCCCCGACAAGGGCGGCGGTTCCCTGCGGATGTGGAAGCGCTACTTCCCGCGCGCCCTGGTCTACGGCATCGACATCGCCGACAAGCGGGCGCTGTCGGAGCAGCGGATCACCGTACTGCGCGCCGACCAGTCGAACGCCGACGAACTGCACGAGGTGGTCGAGCAGACGGGCCCCCTGGACATCGTGATCGACGACGGGAGCCATCGCAGCGAGCACGTCCTGACGTCCTTCACCACGTTGTTTCCGCACCTGAGAGACGGCGGCCTGTATGTGATCGAGGACCTGCAGACCTCCTACTGGCCGCGGTTCGGCGGGAACAGCGATGTGTTCGACAGCCCGACGACGAGTGTCGGGTTCCTGAAGTCCCTGGTGGACGCCCTGCACTACGAGGAGATCCTCGACTCCGGCGGGCGGGCGCCCGGCGCGTACGACCGGCTCGTCAAGGGGCTGCACTTCTACCACAACATCGGGTTCGTCGAGAAAGGCCTGAACGCGGAGGGCGGCGGCCCCTCCTGGCTCAGGCATCCGCCCCGCCGCCGGGGCGACCGGGGACCGGCCGGTGACCGTTCATCCTCTCAACCGCCTTCGCACGGACCGAGGTGA	MTGALRGPRAEASSVDSTVARVISAAGCRDEEITSVIESAGPERVAGILVDEIVCRADLPPVELGEGVVVQLLFGHGTRTISHLVQAGPAGVTYEPGGAESPHARIEQDLCEAVRAVFGPHGDRAAATRRLELRGSDTPQAYVLPPTAFWVAQRLLATMDDRDEIGLTELASRYGSDKWGIHRYTQHYQHHFAPLRDRPLTVLEIGVGGLSGGTTGYRAPDKGGGSLRMWKRYFPRALVYGIDIADKRALSEQRITVLRADQSNADELHEVVEQTGPLDIVIDDGSHRSEHVLTSFTTLFPHLRDGGLYVIEDLQTSYWPRFGGNSDVFDSPTTSVGFLKSLVDALHYEEILDSGGRAPGAYDRLVKGLHFYHNIGFVEKGLNAEGGGPSWLRHPPRRRGDRGPAGDRSSSQPPSHGPR	MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR	117.70	gnl|BL_ORD_ID|2003|hsp_num:0	2193			624	807	triclosan
BGC0000875.1|Caprazamycin_26 # 26882 # 28072 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000875.1|Caprazamycin_26 	26882	28072	+	Loose	700	73.9442	oleI	35.29	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCGTGCTCTTCACGACGTCGCCCGGGCTGGGGCACATGTTCCCGGTGGTCTCGCTCGCCTGGGCGCTGCGCGCGGCCGGACACGAGATCCTTCTCGCCACGGCCGGCCGGGCCGAGAGCCATGTCCGGGCCATGGCCGAGGCCGGCCTGCCGGTGGTGGAGGTGCTGAGTGTCGAGCGGACGACCAGAGCCTTCGCCTTCGGGATCAGCGCCTGGCTGAAGCAGGAGGGCAAGGGCATCGCCGGGAGGCCGGACTGGCCCCGGCGGGTGGGCAGGGAGCTGGCGCGTGGCGGGGGCGGGCTGGAGACCGTCGCCCCCATGTACGGCCCCCTCTCCATGGCCATGAGCGACGAGGTGGTGGCCGTCGCCGAGCAATGGCGGCCGGACCTGCTCGTCCACACCCCCATGGAGGGAGCAGGACCGCTGGCCGCGGCCAGGCTCGGCGTGCCCGCTGTGGAGCATCCCTTCGGGTTCAGCCGCAATGACAAGATCGCCCCCGTGCTGCGGGAGTCGATGGACCGGGCCTACCGTGCGCACGGCGTGGCCGGGCTGCCCGAGCGGAGAATCGCCCTGTCCGTCACTCCCGCGAGCATGGCGGGCGAAGCGACCACGGCCTGGCCGATGCGCTACGTACCGTTCAACGGCGGCGGGGTCCTGGCCGACTGGTTGCGGGTGCGGCCGGACCGTCCCCGGGTGGCACTCACTCTCGGGTCCGAGGTGGTGCAGTGGCACAGCGAGCTCGGCCCGCTGTCCTGGGTCACCGAGGTGGCCGCCAACGTGGACGCGGAGTTCGTGCTCGCCGTCGGCGGCGACATCGACCCGGCTCAGCTCGGCGAGCTGCCGGAGAACGTGCGGCCGGCCGGATACGTCCCGCTCAATCAGCTGTTGCCGACCTGCACGGCGGTCATCCATCACGGCGGGTCCGGCAGTACGATGGCTGCGCTGGACGCCGGAATCCCGCAACTGGTGCTGCCACAGAGCGCGGACCAGTTCATCAACGCGAATGCGGTCGTCGGGCGGGGATGCGGCTTGGCGACGGAGGACAAGGTGGACCTCGAACTGATCGTCCGTCTGCTCACCGACCCGCGGCCGGCCGAGGCCGCGGCGCAGGTGCGGGCCGAGCTGCACGGTATGCCCTCGCCTGCCGAGGTGGTGCCCAGGCTGGCCGAACTGGCGAGGAGGGCCTAG	MRVLFTTSPGLGHMFPVVSLAWALRAAGHEILLATAGRAESHVRAMAEAGLPVVEVLSVERTTRAFAFGISAWLKQEGKGIAGRPDWPRRVGRELARGGGGLETVAPMYGPLSMAMSDEVVAVAEQWRPDLLVHTPMEGAGPLAAARLGVPAVEHPFGFSRNDKIAPVLRESMDRAYRAHGVAGLPERRIALSVTPASMAGEATTAWPMRYVPFNGGGVLADWLRVRPDRPRVALTLGSEVVQWHSELGPLSWVTEVAANVDAEFVLAVGGDIDPAQLGELPENVRPAGYVPLNQLLPTCTAVIHHGGSGSTMAALDAGIPQLVLPQSADQFINANAVVGRGCGLATEDKVDLELIVRLLTDPRPAEAAAQVRAELHGMPSPAEVVPRLAELARRA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	93.40	gnl|BL_ORD_ID|1684|hsp_num:0	1824			762	1209	oleandomycin
BGC0000875.1|Caprazamycin_20 # 20751 # 21629 # 1 # ID=1_20;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.720	BGC0000875.1|Caprazamycin_20 	20751	21629	+	Loose	660	45.8246	MexS	33.33	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGCGCGGCGTCGGCATCAACCGCGACCAGTACCCCCGAATCCTCGGCTGCGAGGCGGCGGGGGAGGGACCCGGCGGCACGAGGGTGGTGCTGTACCCCTTGCTGGACTCCCCACCTGGCATGAGCGACGAGACGCTGGTGATGCCCGCGGCCCAGCTGGTCGGTGCCCGGCCCGGCACCCTGGCCGAGTACTTCGCAGCACCCCCCGAGAGCCTGCTGCCGGTCCCTGACCATCTGACCTGGGAGGAGGCGGCGTGCCTGGTGTGCACCTGGCTGCCCGCGTACCGGATGCTGTTCACGAAGGCGGCGCTGCGCCCCGGGGACACCGTGCTCATCCAGGGGGCGGCCGGCGGACTGTCCACCGCGCTGGTCAGCCTGGCAGCGGCGAGCGGAATGCGCACCTGGGTGACCGGCCGGTCCGCCGACAAGCGGGACCTGGCCCGCCGCCTGGGAGCGAGCGCCGCCTTCGAACCGGGAGCCGTGCTGCCCGAACCGGTCGACGCGGTCATCGACAGCGTGGGCAAAGAGACATGGACGCACTCGCTGCGCAGTGTCCGGCACGGCGGCACGGTGGTGGTCGCCGGTGCGACGACGGGAGACGTCCCGCCCGCCCGGCTGCACCGCGTCTACTTCCACCAGATCAACGTCGTGGGCTCCTTCAGCGGCACCCGCGAGGAGTACCGGCGCCTGGTGACGCTGATGCGCACCACCGGTATCAGGCCGCTGGTGGACGATGTGCTGCCGGTCCAGGAGGCGCGCGCGGCACTGAAGCGGCTCGCCGACGGCGACGTACGAGGCAACCTCGTCCTCACCTGGTCCGAGGACGACCGGGAAGCCCACTGCGAGGCGACTCGGCGGATGTCCGTCTGGATCCCCTGA	LRGVGINRDQYPRILGCEAAGEGPGGTRVVLYPLLDSPPGMSDETLVMPAAQLVGARPGTLAEYFAAPPESLLPVPDHLTWEEAACLVCTWLPAYRMLFTKAALRPGDTVLIQGAAGGLSTALVSLAAASGMRTWVTGRSADKRDLARRLGASAAFEPGAVLPEPVDAVIDSVGKETWTHSLRSVRHGGTVVVAGATTGDVPPARLHRVYFHQINVVGSFSGTREEYRRLVTLMRTTGIRPLVDDVLPVQEARAALKRLADGDVRGNLVLTWSEDDREAHCEATRRMSVWIP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	86.14	gnl|BL_ORD_ID|1039|hsp_num:0	1041			174	573	ciprofloxacin; trimethoprim; chloramphenicol
